Veeva Systems (VEEV)

• Market cap: $34.2B
• 1 day: -2.72%
• 5 days: -5.19%
• 1 month: -11.27%
• 3 months: -5.81%
• 6 months: -5.33%
• Year to date: -0.24%
• 1 year: 5.54%
• 5 years: 19.20%
• 10 years: 682.71%
• Sector: Healthcare
• Industry: Health Information Services

About: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Employees: 7,291

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

65% more first-time investments, than exits

New positions opened: 134 | Existing positions closed: 81

24% more call options, than puts

Call options by funds: $358M | Put options by funds: $289M

4% more funds holding

Funds holding: 939 [Q3] → 974 (+35) [Q4]

2.16% more ownership

Funds ownership: 77.57% [Q3] → 79.73% (+2.16%) [Q4]

7% more repeat investments, than reductions

Existing positions increased: 352 | Existing positions reduced: 330

3% more capital invested

Capital invested by funds: $26.4B [Q3] → $27.2B (+$876M) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 16 [Q3] → 16 (+0) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $200 5% downside
• Avg. target: $244 16% upside
• High target: $285 36% upside

9 analyst ratings

• positive: 4 44%
• neutral: 3 33%
• negative: 2 22%

Keybanc Sangita Jain 32% 1-year accuracy 15 / 47 met price target	19% upside $250	Overweight Maintained	16 Apr 2025
JP Morgan Anne Samuel 47% 1-year accuracy 16 / 34 met price target	19% upside $249	Neutral Maintained	20 Mar 2025
Scotiabank Allan Verkhovski 15% 1-year accuracy 2 / 13 met price target	17% upside $245	Sector Perform Maintained	6 Mar 2025
Truist Securities Joe Meares 0 / 0 met price target	3% upside $217	Hold Maintained	6 Mar 2025
Stephens & Co. Jeff Garro 60% 1-year accuracy 6 / 10 met price target	33% upside $280	Overweight Reiterated	6 Mar 2025